Why Celonic is different than other companies?

We minimise the risks in biopharmaceutical and process development because we think far into the future, plan carefully and offer attractive price models. There are no hidden licensing or other costs. You are aiming to develop a new biopharmaceutical product or a new production process? That is what our work is all about.

Celonic covers the entire range of processes from cell line development to drug production according to GMP guidelines. This means that you will have just one contact person in one company. This will reduce the time you spend on project coordination and we will deliver excellently structured processes adapted to your individual requirements.

Celonic is also an ideal partner for companies planning to license processes to other parties.

Our strategies put foresight at the forefront. This means we can reduce, or even avoid, additional costs and extra development time that issues such as bridging studies would involve.